| The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization (NCT05011916) | Zhongshan Ophthalmic Center, Sun Yat-sen University | 2021-08-10 |
| Corneal Crosslinking for Treatment of Corneal Neovascularization (NCT04787471) | Price Vision Group | 2021-05-03 |
| Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment (NCT04620109) | Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd | 2020-08-26 |
| An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization (NCT04215393) | Chengdu Kanghong Biotech Co., Ltd. | 2019-07-18 |
| Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization (NCT02797704) | Rabin Medical Center | 2017-03-02 |
| A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival (NCT01996826) | Reza Dana, MD | 2014-04-01 |
| Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea (NCT01868360) | Balamurali Ambati | 2013-06-01 |
| Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival (NCT01072357) | Reza Dana, MD | 2009-12-01 |
| Bevacizumab for the Treatment of Corneal Neovascularization (NCT00992849) | Chang Gung Memorial Hospital | 2009-05-01 |
| Topical IL-1-Ra for Treatment of Corneal Neovascularization (NCT00915590) | Reza Dana, MD | 2009-04-01 |
| Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery (NCT00769145) | University of Miami | 2008-10-01 |
| Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization (NCT00512876) | Walter Reed Army Medical Center | 2007-08-01 |
| Corneal Thinning During Topical Bevacizumab Therapy (NCT00515684) | Yonsei University | 2007-05-01 |
| Topical Avastin for Treatment of Corneal Neovascularization (NCT00559936) | Massachusetts Eye and Ear Infirmary | 2007-02-01 |
| Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization (NCT00555594) | Asociación para Evitar la Ceguera en México | 2006-09-01 |
| The Effect of Bevacizumab on Corneal Neovascularization (NCT00797303) | Instituto de Olhos de Goiania | 2006-01-01 |
| Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization (NCT00004430) | Medical College of Hampton Roads | 1994-09-01 |
| Photodynamic Therapy With Verteporfin for Corneal Neovascularization (NCT00471406) | Chonnam National University Hospital | |